A biochemistry panel convened by the ESC and ACC recommends refinements to the troponin standard for the diagnosis of acute myocardial infarction.
ecently, the European Society of Cardiology (ESC) and the American College of Cardiology (ACC) convened a conference to discuss refinements in the diagnosis of acute myocardial infarction. The panel on biochemistry considered issues related to the use of marker proteins. We were guided predominantly by the science of the area. We were also cognizant of the impact that changes in the standards would have on epidemiology, clinical trials, education of physicians, and patient care. Our recommendations will be incorporated, with the recommendations of the other panels, into a position paper for the ESC and the ACC. However, the members of the biochemistry group decided to express the opinions we felt were important in this area independently. Our thinking does not represent the position of the ESC, the ACC, or of the conjoint task force.
Jaffe et al. (Tue,) conducted a editorial in Acute myocardial infarction. Troponin standard was evaluated. A biochemistry panel convened by the ESC and ACC recommends refinements to the troponin standard for the diagnosis of acute myocardial infarction.